Search Results

You are looking at 81 - 90 of 886 items for :

  • "risk factor" x
  • Refine by Access: All x
Clear All
Full access

Impact of Nonadherence to NCCN Adjuvant Radiotherapy Initiation Guidelines in Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population

Anusha Ponduri, David Z. Liao, Nicolas F. Schlecht, Gregory Rosenblatt, Michael B. Prystowsky, Rafi Kabarriti, Madhur Garg, Thomas J. Ow, Bradley A. Schiff, Richard V. Smith, and Vikas Mehta

intervene in a prospective fashion. In this study, we sought to measure the impact of nonadherence to NCCN Guidelines on survival and disease recurrence in patients with HNSCC at a large urban health center, and investigated risk factors predictive of delay

Full access

Efficacy and Toxicity Analysis of Capecitabine and Temozolomide in Neuroendocrine Neoplasms

Taymeyah Al-Toubah, Eleonora Pelle, Tiffany Valone, Mintallah Haider, and Jonathan R. Strosberg

gastrointestinal NETs. Although moderately powered studies are sufficient to determine critical outcomes such as ORR and PFS, larger databases are key to answering other important questions. These include the frequency of rare toxicities, risk factors for

Full access

Complications of Multiple Myeloma Therapy, Part 1: Risk Reduction and Management of Peripheral Neuropathy and Asthenia

Paul G. Richardson, Jacob P. Laubach, Robert L. Schlossman, Constantine Mitsiades, and Kenneth Anderson

neuropathy may be detected in 11% to 52% and 39% to 46% of these populations, respectively. 1 – 6 Risk factors for PN include treatment-specific characteristics, such as therapy duration, dose intensity, and cumulative dose, and patient-specific factors

Full access

Risk Stratification and Emerging Treatment Strategies in Acute Myeloid Leukemia

Margaret R. O’Donnell

“In the majority of our patients, the major risk factor for whether they will do well or poorly is related to their cytogenetic and/or molecular markers,” stated Margaret R. O’Donnell, MD, Associate Clinical Director, Division of Hematology and

Full access

Health Behaviors and Quality of Life Among Colorectal Cancer Survivors

Elizabeth A. Rohan, Julie S. Townsend, Temeika L. Fairley, and Sherri L. Stewart

addressed in interventions. Methods Behavioral Risk Factor Surveillance System Survey This study used the Behavioral Risk Factor Surveillance System (BRFSS), a state-based system of health surveys that collects information on health risk

Full access

Alcohol Use Among Patients With Cancer and Survivors in the United States, 2000–2017

Nina N. Sanford, David J. Sher, Xiaohan Xu, Chul Ahn, Anthony V. D’Amico, Ayal A. Aizer, and Brandon A. Mahal

Background Alcohol use has been identified as a risk factor for several malignancies, including cancers of the head and neck, esophagus, colorectum, liver, and breast. 1 – 3 Epidemiologic studies have shown that higher alcohol consumption over

Full access

Role of Surgery for Locally Advanced and Metastatic Renal Cell Carcinoma

Robert Torrey, Philippe E. Spiess, Sumanta K. Pal, and David Josephson

study from MD Anderson Cancer Center, adverse risk factors were described as positive local recurrence margin, increased size of recurrence, presence of sarcomatoid features, and abnormal serum alkaline phosphatase or lactate dehydrogenase. Patients with

Full access

Radiation Therapy and Breast Cancer Risk

Andrea K. Ng and Lois B. Travis

.9%. 61 Although these excesses are largely related to preexisting breast cancer risk factors, prior radiation therapy, especially treatment at a young age, may contribute to the increased risk. 28 - 30 , 62 In early case-control studies by Storm et al

Full access

Pancreatic Adenocarcinoma

Margaret A. Tempero, J. Pablo Arnoletti, Stephen Behrman, Edgar Ben-Josef, Al B. Benson III, Jordan D. Berlin, John L. Cameron, Ephraim S. Casper, Steven J. Cohen, Michelle Duff, Joshua D.I. Ellenhorn, William G. Hawkins, John P. Hoffman, Boris W. Kuvshinoff II, Mokenge P. Malafa, Peter Muscarella II, Eric K. Nakakura, Aaron R. Sasson, Sarah P. Thayer, Douglas S. Tyler, Robert S. Warren, Samuel Whiting, Christopher Willett, and Robert A. Wolff

unanimously endorses participation in a clinical trial as the preferred option over standard or accepted therapy. Risk Factors and Genetic Predisposition Although the associated increase in risk is small, the development of pancreatic cancer is firmly

Full access

Cardiovascular Health and Risk Management in Cancer Survivors

Presented by: Javid J. Moslehi

-oncology. “Common risk factors predispose people to both cardiovascular disease and cancer. This has major implications for patients about to undergo systemic cancer treatment and also implications for survivorship,” he told the audience at the NCCN 2020 Virtual